《Zeitschrift Fur Rheumatologie》重点专注发布医学-风湿病学领域的新研究,旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今,在医学-风湿病学领域,有较高影响力,对来稿文章质量要求较高,稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
CiteScore | SJR | SNIP | CiteScore排名 | |||
---|---|---|---|---|---|---|
2.2 | 0.26 | 0.344 | 学科类别 | 分区 | 排名 | 百分位 |
大类:大类:Medicine
小类:小类:Rheumatology
|
Q3 | 47/73 | 36% |
按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:RHEUMATOLOGY | SCIE | Q4 | 51 / 57 | 11.4% |
按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
---|---|---|---|---|
学科:RHEUMATOLOGY | SCIE | Q4 | 48 / 57 | 16.67% |
文章名称
引用次数
S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs
18
Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis A Bayesian network meta-analysis of randomized controlled trials
7
S3 guidelines on treatment of polymyalgia rheumatica. Evidence-based guidelines of the German Society of Rheumatology (DGRh), the Austrian Society of Rheumatology and Rehabilitation (OGR) and the Swiss Society of Rheumatology (SGT) and participatingmedical scientific specialist societies and other organizations
7
Long-term trends in rheumatology care. Achievements and deficits in 25 years of the German national rheumatology database
6
Multimodal rheumatologic complex treatment of rheumatoid arthritis-a monocentric retrospective analysis
6
New inflammatory markers in early rheumatoid arthritis
6
Use of medical apps and online platforms among German rheumatologists Results of the 2016 and 2018 DGRh conference surveys and research conducted by rheumadocs
6
Comparison of the efficacy and safety of tofacitinib and baricitinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
5
Response of Dermatomyositis with Lung Involvement to a Janus Kinase Inhibitor Treatment
5
Pulmonary involvement in rheumatoid arthritis
5
国家/地区
发文量
TGERMANY (FED REP GER)
414
TSouth Korea
34
TSwitzerland
26
TCHINA MAINLAND
20
TAustria
15
TTurkey
10
TEgypt
9
TEngland
5
TItaly
4
TFrance
2





